Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration.

Tiantian Ye, Yue Wu, Lei Shang, Xueqing Deng, Shujun Wang
Author Information
  1. Tiantian Ye: a Department of Pharmaceutics, School of Pharmacy , Shenyang Pharmaceutical University , Shenyang , China.
  2. Yue Wu: b Department of Pharmaceutics, School of Chinese Medicines , Shenyang Pharmaceutical University , Shenyang , China.
  3. Lei Shang: c Shenyang Medical College , Shenyang , China.
  4. Xueqing Deng: b Department of Pharmaceutics, School of Chinese Medicines , Shenyang Pharmaceutical University , Shenyang , China.
  5. Shujun Wang: a Department of Pharmaceutics, School of Pharmacy , Shenyang Pharmaceutical University , Shenyang , China.

Abstract

Borneol as a penetration enhancer is widely used in guiding other components through the biological barrier into the targeting organs or tissues. This study aimed at studying effect and mechanism of synthetic borneol (S-BO) on improving lymphatic-targeting ability of 7-ethyl-10-hydroxycamptothecin liposomes (SN-38-Lips) via increasing lymph node uptake. At first, SN-38-Lips prepared had appropriate particle distribution, drug loading property and compatible stability with S-BO. Both in vitro cellular uptake and in vivo fluorescence imaging showed that 2 and 5 mg/mL S-BO, especially 2 mg/mL S-BO, enhanced cytoplasmic fluorescence signal of SN-38-Lips in the macrophages based on phagocytosis effect. And high-intensity zone appeared in the paracortex and medulla of popliteal lymph node. SN-38-Lips were subcutaneously (s.c.) injected into the right footpad of KM rats in the dose of 4 mg/kg following s.c. injection of 1, 2 and 5 mg/mL BO suspension. The lymphatic pharmacokinetics were investigated to explore the promotion law of S-BO, and combined with tissue irritation to optimize S-BO concentrations. The results indicated that 2 mg/mL S-BO could reduce injection-site retention, and prolong residence time and increase uptake of lymph nodes, which would not cause inflammatory reaction of injection site. In conclusion, the present study may provide a basic study for improving lymphatic-targeting ability of SN-38-Lips by the S-BO regulation, and to be the helpful guidance for further study in lymphatic targeting of delivery system.

Keywords

References

  1. Lymphology. 1980 Dec;13(4):177-83 [PMID: 7010001]
  2. Expert Opin Drug Deliv. 2014 Feb;11(2):211-29 [PMID: 24350774]
  3. J Control Release. 2002 Feb 19;79(1-3):29-40 [PMID: 11853916]
  4. Pharm Biol. 2016 Dec;54(12):3009-3018 [PMID: 27431008]
  5. Biochim Biophys Acta. 2008 Jan;1778(1):51-5 [PMID: 17936719]
  6. Biochim Biophys Acta. 1993 Jul 25;1150(1):9-16 [PMID: 8334142]
  7. Drug Dev Ind Pharm. 2016;42(7):1086-93 [PMID: 26635061]
  8. Biochim Biophys Acta. 1997 Sep 4;1328(2):261-72 [PMID: 9315622]
  9. Carbohydr Polym. 2015 May 20;122:26-38 [PMID: 25817639]
  10. J Ethnopharmacol. 2015 Mar 13;162:270-7 [PMID: 25582491]
  11. Biomaterials. 2003 Aug;24(18):3005-12 [PMID: 12895572]
  12. Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):901-8 [PMID: 21712055]
  13. Drug Deliv. 2016 Nov;23(9):3417-3423 [PMID: 27174642]
  14. Adv Drug Deliv Rev. 2001 Aug 23;50(1-2):3-20 [PMID: 11489331]
  15. PLoS One. 2013 May 20;8(5):e63502 [PMID: 23700426]
  16. Drug Dev Ind Pharm. 2013 Feb;39(2):393-401 [PMID: 22583043]
  17. Drug Deliv. 2017 Nov;24(1):422-429 [PMID: 28165806]
  18. Drug Deliv. 2017 Nov;24(1):1037-1044 [PMID: 28687052]
  19. Neuroreport. 2017 Jun 14;28(9):506-513 [PMID: 28471848]
  20. Int J Pharm. 2007 Jun 7;337(1-2):74-9 [PMID: 17275227]
  21. PLoS One. 2014 Jul 03;9(7):e101414 [PMID: 24992195]
  22. Drug Deliv. 2016 Sep;23(7):2617-2629 [PMID: 26017243]
  23. Environ Toxicol Pharmacol. 2010 May;29(3):229-34 [PMID: 21787607]
  24. Lung. 2012 Jun;190(3):251-62 [PMID: 22274758]
  25. Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):867-75 [PMID: 21699937]
  26. Int J Pharm. 2014 Aug 25;471(1-2):245-57 [PMID: 24858386]
  27. Int J Mol Sci. 2012 Nov 01;13(11):14127-35 [PMID: 23203054]
  28. Am J Surg. 2009 Dec;198(6):781-6 [PMID: 19969129]

MeSH Term

Administration, Cutaneous
Animals
Biological Transport
Camptothecin
Irinotecan
Liposomes
Lymph Nodes
Lymphatic System
Male
Mice
Nanoparticles
RAW 264.7 Cells
Rats
Tissue Distribution

Chemicals

Liposomes
Irinotecan
Camptothecin

Word Cloud

Created with Highcharts 10.0.0S-BOSN-38-Lipslymphuptakestudynodelymphatictargetingeffectborneol7-ethyl-10-hydroxycamptothecinmechanismsyntheticimprovinglymphatic-targetingabilityfluorescence25 mg/mL2 mg/mLscfollowinginjectionBorneolpenetrationenhancerwidelyusedguidingcomponentsbiologicalbarrierorganstissuesaimedstudyingliposomesviaincreasingfirstpreparedappropriateparticledistributiondrugloadingpropertycompatiblestabilityin vitrocellularin vivoimagingshowedespeciallyenhancedcytoplasmicsignalmacrophagesbasedphagocytosishigh-intensityzoneappearedparacortexmedullapoplitealsubcutaneouslyinjectedrightfootpadKMratsdose4 mg/kg1BOsuspensionpharmacokineticsinvestigatedexplorepromotionlawcombinedtissueirritationoptimizeconcentrationsresultsindicatedreduceinjection-siteretentionprolongresidencetimeincreasenodescauseinflammatoryreactionsiteconclusionpresentmayprovidebasicregulationhelpfulguidancedeliverysystemImprovedtargeting:nanoliposomessubcutaneousadministrationSyntheticnanoliposome

Similar Articles

Cited By